Related Experiment Videos
Hyperglycemic pseudorejection in the diabetic transplant patient
Surgery
|February 1, 1976
Summary
Hyperglycemia in diabetic transplant patients can falsely elevate serum creatinine, mimicking rejection. Managing blood glucose levels normalizes creatinine, avoiding unnecessary rejection treatments.
Area of Science:
- Nephrology
- Endocrinology
- Transplantation
Background:
- Serum creatinine elevation in transplant recipients typically indicates organ rejection, necessitating intervention.
- Diabetic patients receiving kidney transplants are a vulnerable population requiring careful monitoring post-surgery.
Observation:
- A frequent observation in juvenile diabetic kidney transplant recipients was elevated serum creatinine coinciding with hyperglycemia.
- This elevation was not attributed to laboratory artifacts but potentially to hyperosmolarity and dehydration.
Findings:
- In 52 stable diabetic transplant patients, a 100 mg/dL increase in blood glucose correlated with a 0.5 mg/dL rise in serum creatinine (r=0.93, p<0.001).
- Correcting hyperglycemia restored serum creatinine to normal levels, resolving the apparent rejection.
- This suggests a direct link between glycemic control and serum creatinine levels in this cohort.
Implications:
- Recognition of hyperglycemia-induced creatinine elevation is crucial for accurate diagnosis in diabetic transplant recipients.
- This syndrome can prevent unnecessary immunosuppression and rejection therapy, improving patient outcomes.
- Highlights the importance of integrated care for diabetes and kidney transplantation.